ABSTRACT In order to determine the specific structural properties responsible for neurotoxic activity, the comparative neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanedione, and their relatives was investigated in the peripheral nerves of rats. The maximum conduction velocity of motor and sensory fibres and the motor distal latency of the tail nerves of rats were periodically examined in animals receiving repeated subcutaneous injections of 11 aliphatic monoketone or diketone compounds and their relatives for prolonged periods. A study of the comparative neurotoxicity of n-hexane, methyl n-butyl ketone, and their metabolites showed that 2,5-hexanedione was the most actively neurotoxic. Furthermore, a study of other symmetrical diketones with different carbon numbers showed that 2,4-pentanedione, which is structurally similar to 2,5-hexanedione, possessed a different type of neurotoxic activity than 2,5-hexanedione. Regarding aliphatic monoketone compounds, acetone, 2-pentanone, 2-heptanone, and 2-octanone were confirmed non-neurotoxic for the peripheral nervous system. Evidence from some previous reports, however, suggested that 3-heptanone, 4-octanone, and 5-nonanone might produce neuropathies by being converted to 2,5-diketones under specific conditions. N-hexane and methyl n-butyl ketone (MnBK) are widely used in industry and they share the metabolites, 2-hexanol and 2,5-hexanedione, in common.' 7One of these metabolites, 2,5-hexanedione, was considered to be responsible for the development of neuropathy after exposure to n-hexane or MnBK, since the histopathological changes observed in neuropathy due to 2,5-hexanedione8 were similar to those produced by MnBK9-'2 or n-hexane.'3 A comparative study of the neurotoxicity of hexacarbon compounds and their relatives has shown that 2,5-hexanedione was the most active neurotoxin for the peripheral nerves of rat. Investigations of the neurotoxicity of aliphatic diketone compounds by Krasavage et all4 and Spencer et al '5 have shown that a specific structural property, the y diketone spacing, is necessary for neurotoxic activity. They termed the neuropathy due to 2,5-diketones "y-neuropathy." These results suggested that it would be interesting to study the symmetrical diketones of 4-carbon or 5-carbon aliphatic compounds. A study of the neurotoxicity of 2,4-pentanedione in our laboratory has shown that this compound possessed neurotoxic activity,'6 17 and that the neurotoxic activity of this compound was not distal dominant as with 2,5-hexanedione. This result suggests the necessity of a more systematic assay of 2,3-butanedione, 2,4-pentanedione, and 2,5-hexanedione because it is not clear whether or not 2,3-butanedione possesses neurotoxic activity.'6 17 In addition, repeated injections of 2-pentanone, 2-heptanone, or 2-octanone analogous to MnBK into the backs of rats do not produce signs of peripheral neuropathy.'8-20
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Results

CLINICAL FEATURES
The clinical signs which were observed are summarised in table 3. All the n-hexane, MnBK, 2-hexanol 2,4-pentanedione and 2,3-butanedione treated groups showed a retardation of normal growth, and the 2,5-hexanedione and 2,5-hexanediol groups showed a loss of body weight as compared with that
Misumi and Nagano at the beginning of treatment. The animals treated with MnBK, 2-hexanol, 2,5-hexanediol, and 2,5-hexanedione showed disturbances in gait and the 2,5-hexanediol and 2,5-hexanedione groups suffered severe paralysis of their hind limbs. The neurological signs observed in these groups have been described elsewhere. '61723 In the pentanone group increased salivation in four of the eight animals was observed during the later stages of the experiment. In the 2,4-pentanedione group increased salivation on the 15th day of treatment was also observed in four of the six animals, and these four animals showed disturbances in gait on the 45th day. Thereafter, all the animals developed a spastic paralysis of the hind limbs but were not flaccid as were the animals receiving 2,5-hexanedione. The other groups remained more or less normal throughout the experiments. Table 4 summarises the results of the conduction velocities and motor distal latency in the tail nerve of the rats. As indicated in table 4, in the MnBK, 2-hexanol, 2,5-hexanediol, and 2,5-hexanedione In order to compare the potency of neurotoxic activity of the chemical substances being tested, the mean accumulated total doses at that time when a significant slowing in conduction velocity began to be observed, were investigated. Table 5 summarises the relations between the mean total doses (g) per animal for the respective compounds and the slowing of conduction velocities.
NEUROPHYSIOLOGICAL FINDINGS
In the 2,5-hexanedione group the time of the onset of a slowing in conduction velocity was dose dependent-that is, in the group receiving a dose of 400 mg/kg/day an accumulated mean total dose of less than 1-4 g of the compound produced a slowing in conduction velocity. In the group in which the daily dose was 300 mg/kg, a mean total dose of 2 1 g produced a significant slowing in conduction velocity, and in the group receiving a daily dose of 200 mg/kg the same result began to be observed when the mean total dose was about 2-4 g.
In the MBK group a slowing in conduction velocity occurred when the mean total dose of the com- group.bmj.com on October 19, 2017 -Published by http://oem.bmj.com/ Downloaded from pound reached 6-7 g; in the 2-hexanol group this took place after 9-6 g of the compound had been injected and in the 2,5-hexanediol group after 4-0 g had been administered. The time of onset of the slowing of the SCVs in the 2,4-pentanedione group was approximately similar to that in the 2,5-hexanedione group, but a retardation in the MCVs was observed after a total dose of 2-9 g, which was greater than that of the 2,5-hexanedione group.
Discussion
The present study has confirmed two points: firstly, 2-hexanol, 2,5-hexanediol, 2,5-hexanedione, intermediate metabolites of n-hexane, and MnBK are all neurotoxic. Secondly, the neurotoxic potency among the five hexacarbon compounds shown in table 1 may be ranked in the order 2,5-hexanedione, 2,5-hexanediol, MnBK, 2-hexanol, and n-hexane. Figure 2 shows the relative neurotoxicity of n-hexane, MnBK, and their metabolites. The ratio of the mean total dose of the respective compounds required to produce a decrease in the conduction velocity similar to that of MnBK was calculated in the form of a neurotoxic index in which the neurotoxicity of MnBK was regarded as 1-0. The neurotoxic indices of 2,5-hexanedione, 2,5-hexanediol, 2-hexanol, and n-hexane were 4-6, 1.6, 0-68, and less than 0 58 (fig 2) . This agrees with the results obtained by Krasavage et al in their investigation of the number of days it took to develop neuropathy. '4 The animals treated with daily doses of 200 mg/kg of 2,4-pentanedione exhibited clinical and neurophysiological evidence of neuropathy, but repeated subcutaneous injections of 400 mg/kg/day of the compound caused the deaths of all seven animals and were accompanied by increased salivation, convulsions, and ataxia of hind limbs; no animals died as the result of repeated injections of equivalent amounts of 2,5-hexanedione. It is difficult to compare the neurotoxic potency of 2,4-pentanedione with that of 2,5-hexanedione because the type of neurotoxicity of 2,4-pentanedione seems to differ from that of 2,5-hexanedione. But, considering only the peripheral nerves, the neurotoxicity of this compound seems to be less than that of 2,5-hexanedione, whereas its neurotoxic activity in the central nervous system is greater than that of 2,5-hexanedione.
The compound 2,3-butanedione was considered non-neurotoxic because, in this group of animals, no definite slowing in the conduction velocity of the tail nerve was observed. The decreased conduction velocity seen in the last stage of the experiment in which daily doses of 400 mg/kg were given was considered to be due to the low haemoglobin levels seen The results of the present study, and some from earlier studies, are summarised in table 6. Monoketone compounds which may be expected to be converted to 2,5-diketone are neurotoxic and in addition, it has been found that 2,4-pentanedione is also neurotoxic. 2,4-Pentanedione forms chelates with copper, iron and cobalt and this ability to chelate with metals might be concerned with the development of neuropathy by interfering with coenzymes. For this reason it seems important to investigate whether or not this property is generally related to neurotoxic activity.
